These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 14524058

  • 1. [Quality of antithrombotic therapy in patients with chronic atrial fibrillation: the AFib Trial].
    Bücheler R, Meisner C, Mörike K, Fux R, Hauswald K, Lorenz G, Kühlkamp V, Gleiter CH, AFib Trial.
    Z Arztl Fortbild Qualitatssich; 2003; 97(6):421-31. PubMed ID: 14524058
    [Abstract] [Full Text] [Related]

  • 2. Population-based evaluation of the management of antithrombotic therapy for atrial fibrillation.
    Anderson DR, Gardner MJ, Putnam W, Jassal D, Brownell B, Flowerdew G, Nagpal S, Thompson K, Cox JL.
    Can J Cardiol; 2005 Mar; 21(3):257-66. PubMed ID: 15776115
    [Abstract] [Full Text] [Related]

  • 3. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
    Lin LJ, Cheng MH, Lee CH, Wung DC, Cheng CL, Kao Yang YH.
    Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
    [Abstract] [Full Text] [Related]

  • 4. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.
    Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
    [Abstract] [Full Text] [Related]

  • 5. Guideline-adherent antithrombotic treatment is associated with improved outcomes compared with undertreatment in high-risk patients with atrial fibrillation. The Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R, Olsson SB, Lip GY, Camm AJ, Breithardt G, Capucci A, Meeder JG, Prins MH, Lévy S, Crijns HJ, Euro Heart Survey Investigators.
    Am Heart J; 2007 Jun; 153(6):1006-12. PubMed ID: 17540203
    [Abstract] [Full Text] [Related]

  • 6. Influence of age on the prescription of vitamin K antagonists in outpatients with permanent atrial fibrillation in France.
    FALSTAF Study GroupService de Pharmacologie Clinique, EA 3736, Faculté R.T.H. Laennec, Université Lyon 1, Rue Guillaume Paradin, BP 8071-69376 LYON cedex 08, France., Leizorovicz A, Cohen A, Guenoun M, Mismetti P, Weisslinger N.
    Pharmacoepidemiol Drug Saf; 2007 Jan; 16(1):32-8. PubMed ID: 17063535
    [Abstract] [Full Text] [Related]

  • 7. Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
    Glazer NL, Dublin S, Smith NL, French B, Jackson LA, Hrachovec JB, Siscovick DS, Psaty BM, Heckbert SR.
    Arch Intern Med; 2007 Feb 12; 167(3):246-52. PubMed ID: 17296879
    [Abstract] [Full Text] [Related]

  • 8. Optimizing the use of antithrombotic therapy for atrial fibrillation in older people: a pharmacist-led multidisciplinary intervention.
    Bajorek BV, Krass I, Ogle SJ, Duguid MJ, Shenfield GM.
    J Am Geriatr Soc; 2005 Nov 12; 53(11):1912-20. PubMed ID: 16274372
    [Abstract] [Full Text] [Related]

  • 9. Antithrombotic therapy for prevention of stroke in clinical practice in the ED.
    Kogan A, Shapira R, Tamir A, Rennert G.
    Am J Emerg Med; 2007 Jan 12; 25(1):1-5. PubMed ID: 17157674
    [Abstract] [Full Text] [Related]

  • 10. [The PreFord Study. A prospective cohort study to evaluate the risk of a cardiovascular event (overall-collective) as well as a prospective, randomized, controlled, multicentre clinical intervention study (high-risk-collective) on primary prevention of cardiovascular diseases in the Ford Motor Company employees in Germany].
    Gysan DB, Latsch J, Bjarnason-Wehrens B, Albus C, Falkowski G, Herold G, Mey E, Heinzler R, Montiel G, Schneider CA, Stützer H, Türk S, Weisbrod M, Predel HG.
    Z Kardiol; 2004 Feb 12; 93(2):131-6. PubMed ID: 14963679
    [Abstract] [Full Text] [Related]

  • 11. [Nonvalvular atrial fibrillation: thromboembolic risk assessment and therapy in a general practice population].
    Del Zotti F, Gottardi G, Frapporti G, Micchi A, Zanolla L.
    G Ital Cardiol (Rome); 2010 Apr 12; 11(4):313-7. PubMed ID: 20677578
    [Abstract] [Full Text] [Related]

  • 12. Comparing the guidelines: anticoagulation therapy to optimize stroke prevention in patients with atrial fibrillation.
    Rockson SG, Albers GW.
    J Am Coll Cardiol; 2004 Mar 17; 43(6):929-35. PubMed ID: 15028346
    [Abstract] [Full Text] [Related]

  • 13. Antithrombotic drug prescription in atrial fibrillation and its rationale among general practitioners, internists and cardiologists in The Netherlands--The EXAMINE-AF study. A questionnaire survey.
    Dinh T, Nieuwlaat R, Tieleman RG, Büller HR, van Charante NA, Prins MH, Crijns HJ.
    Int J Clin Pract; 2007 Jan 17; 61(1):24-31. PubMed ID: 17229177
    [Abstract] [Full Text] [Related]

  • 14. [Modification of clinical profile of stroke in atrial fibrillation patients. Effect of antithrombotic treatment].
    García Escrivà A, López Hernández N, Hernández Lorido R, Oliver Navarrete C, Bustos S, Carneado Ruiz J, Gracia Fleta F, Moltó Jordá JM.
    Rev Neurol; 2007 Jan 17; 38(5):401-5. PubMed ID: 15029514
    [Abstract] [Full Text] [Related]

  • 15. Dilemma of antithrombotic therapy in anticoagulated atrial fibrillation patients squeezed between thrombosis and bleeding events: a single-centre experience.
    Halbfass P, Janko S, Dorwarth U, Riess G, Antoni D, Hoffmann E.
    Europace; 2009 Jul 17; 11(7):957-60. PubMed ID: 19493910
    [Abstract] [Full Text] [Related]

  • 16. Novel antithrombotic therapies for the prevention of stroke in patients with atrial fibrillation.
    O'Donnell M, Weitz JI.
    Am J Manag Care; 2004 Apr 17; 10(3 Suppl):S72-82. PubMed ID: 15152749
    [Abstract] [Full Text] [Related]

  • 17. Stroke prevention in hospitalized patients with atrial fibrillation: a population-based study.
    Nagpal S, Anderson D, Putnam W, Flowerdew G, Gardner M, Cox J.
    Can J Clin Pharmacol; 2003 Apr 17; 10(4):197-201. PubMed ID: 14712325
    [Abstract] [Full Text] [Related]

  • 18. Antithrombotic therapy in atrial fibrillation: an assessment of compliance with guidelines.
    Nair A, Hazell W, Sutton T, Pillai S.
    N Z Med J; 2005 Jan 28; 118(1208):U1258. PubMed ID: 15682210
    [Abstract] [Full Text] [Related]

  • 19. Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on Atrial Fibrillation.
    Nieuwlaat R, Capucci A, Lip GY, Olsson SB, Prins MH, Nieman FH, López-Sendón J, Vardas PE, Aliot E, Santini M, Crijns HJ, Euro Heart Survey Investigators.
    Eur Heart J; 2006 Dec 28; 27(24):3018-26. PubMed ID: 16731536
    [Abstract] [Full Text] [Related]

  • 20. Initiation of oral anticoagulation after acute ischaemic stroke or transient ischaemic attack: timing and complications of overlapping heparin or conventional treatment.
    Audebert HJ, Schenk B, Tietz V, Schenkel J, Heuschmann PU.
    Cerebrovasc Dis; 2008 Dec 28; 26(2):171-7. PubMed ID: 18628615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.